Abstract
Many countries have implemented school closures as part of social distancing measures intended to control the spread of coronavirus disease 2019 (COVID-19). The aim of this study was to assess the early impact of nationwide school closure (March-May 2020) and social distancing for COVID-19 on the number of inpatients with major childhood infectious diseases in Japan. Using data from the Diagnosis Procedure Combination system in Japan, we identified patients aged 15 years or younger with admissions for a diagnosis of upper respiratory tract infection (URTI), lower respiratory tract infection (LRTI), influenza, gastrointestinal infection (GII), appendicitis, urinary tract infection (UTI), or skin and soft tissue infection (SSTI) between July 2018 and June 2020. Two periods were considered in the analysis: a pre- and a post-school-closure period. Changes in the trend of the weekly number of inpatients between the two periods were assessed using interrupted time-series analysis. A total of 75,053 patients in 210 hospitals were included. We found a marked reduction in the number of inpatients in the post-school-closure period, with an estimated reduction of 581 (standard error 42.9) inpatients per week (p < 0.001). The main part of the reduction was for pre-school children. Remarkable decreases in the number of inpatients with URI, LRTI, and GII were observed, while there were relatively mild changes in the influenza, appendicitis, UTI, and SSTI groups. We confirmed a marked reduction in the number of inpatients with childhood non-COVID-19 acute infections in the post-school-closure period.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study was supported by the Japan Society for the Promotion of Science [JSPS KAKENHI Grant Number JP19H01075 to Y.I.] and GAP Fund Program of Kyoto University.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
This study was approved by the Ethics Committee, Graduate School of Medicine, Kyoto University (approval number: R0135).
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
ken{at}yacht.ocn.ne.jp
bun.seiko.58w{at}st.kyoto-u.ac.jp
shin.jungho.76v{at}st.kyoto-u.ac.jp
daisuke.gaotian{at}gmail.com
morishita.tetsuji.42z{at}st.kyoto-u.ac.jp
kunisawa.susumu.2v{at}kyoto-u.ac.jp
imanaka-y{at}umin.net
Data Availability
The datasets analyzed during the current study available from the corresponding author on reasonable request.
